Wabtec Work in process remained flat by 0.0% to $698.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.5%, from $668.00M to $698.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 15.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $314.50M | $342.00M | $316.00M | $393.00M | $427.00M | $534.00M | $515.00M | $510.00M | $545.00M | $518.00M | $463.00M | $591.00M | $573.00M | $590.00M | $587.00M | $668.00M | $759.00M | $826.00M | $698.00M | $698.00M |
| QoQ Change | — | +8.7% | -7.6% | +24.4% | +8.7% | +25.1% | -3.6% | -1.0% | +6.9% | -5.0% | -10.6% | +27.6% | -3.0% | +3.0% | -0.5% | +13.8% | +13.6% | +8.8% | -15.5% | +0.0% |
| YoY Change | — | — | — | — | +35.8% | +56.1% | +63.0% | +29.8% | +27.6% | -3.0% | -10.1% | +15.9% | +5.1% | +13.9% | +26.8% | +13.0% | +32.5% | +40.0% | +18.9% | +4.5% |
| % of Inventories | 18.9% | 20.2% | 18.7% | 21.5% | 22.3% | 26.4% | 25.3% | 22.9% | 23.5% | 23.1% | 20.3% | 25.1% | 24.2% | 24.8% | 25.4% | 28.1% | 29.5% | 30.1% | 25.4% | 24.5% |
| Share Change | — | +1.3pp | -1.5pp | +2.8pp | +0.8pp | +4.1pp | -1.1pp | -2.4pp | +0.6pp | -0.5pp | -2.8pp | +4.8pp | -0.8pp | +0.6pp | +0.6pp | +2.7pp | +1.4pp | +0.5pp | -4.6pp | -0.9pp |